Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hamsten

Showing results (141-150 of 244) with videos related to

Pageof 25
Sort By:
Cardiovascular Drugs and Therapy|May 1, 1997
Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trialsU de Faire, C G Ericsson, L Grip, et al.
The Journal of Biological Chemistry|May 25, 1993
The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cellsS J Dawson, B Wiman, A Hamsten, et al.
Cardiology|August 7, 1998
Diastolic and systolic function as predictors of exercise capacity after myocardial infarction in young MenS V Eriksson, K Caidahl, U de Faire, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2000
Functional characterization of 4 polymorphisms in promoter region of hepatic lipase geneF M van't Hooft, B Lundahl, F Ragogna, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2001
Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patientsS Jormsjö, C Whatling, D H Walter, et al.
Cardiovascular Research|June 28, 2003
Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDLG D Norata, A Pirillo, E Callegari, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory responseM van Rooijen, L O Hansson, J Frostegård, et al.
Atherosclerosis|June 11, 1998
Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular riskS Boquist, G Ruotolo, M L Hellénius, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 1999
LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old menC Skoglund-Andersson, R Tang, M G Bond, et al.
Circulation|January 25, 2000
Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery diseaseJ Björkegren, S Boquist, A Samnegârd, et al.
Pageof 25

Showing results (141-150 of 244) with videos related to

Sort By:
Pageof 25
Cardiovascular Drugs and Therapy|May 1, 1997
Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trialsU de Faire, C G Ericsson, L Grip, et al.
The Journal of Biological Chemistry|May 25, 1993
The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cellsS J Dawson, B Wiman, A Hamsten, et al.
Cardiology|August 7, 1998
Diastolic and systolic function as predictors of exercise capacity after myocardial infarction in young MenS V Eriksson, K Caidahl, U de Faire, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2000
Functional characterization of 4 polymorphisms in promoter region of hepatic lipase geneF M van't Hooft, B Lundahl, F Ragogna, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2001
Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patientsS Jormsjö, C Whatling, D H Walter, et al.
Cardiovascular Research|June 28, 2003
Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDLG D Norata, A Pirillo, E Callegari, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory responseM van Rooijen, L O Hansson, J Frostegård, et al.
Atherosclerosis|June 11, 1998
Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular riskS Boquist, G Ruotolo, M L Hellénius, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 1999
LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old menC Skoglund-Andersson, R Tang, M G Bond, et al.
Circulation|January 25, 2000
Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery diseaseJ Björkegren, S Boquist, A Samnegârd, et al.
Pageof 25